NAVROGEN INC

Capabilities

?Discovery & Preclinical Development of Therapeutic Monoclonal Antibodies, Immunotoxins, Bispecific mAbs, and Antibody-Drug Conjugates ?Drug Screening & Drug Candidate Selection using In Vitro Cell-Based Assays and In Vivo Preclinical Animal Models for Cancer & Immunological Diseases ?Conceiving & Advancing New Biological Technology Platforms ?Validation of Cancer-Associated Targets and Disease Association Analyses ?Optimization & Development of In Vitro and In Vivo Preclinical Models ?Preliminary Toxicology in Small Animals and Non-Human Primates